[Biomaterials for reconstruction and bone substitution in otorhinolaryngology and head and neck surgery].
BACKGROUND
Position of medical devices has increased for last 30 years in otorhinolaryngology. Legal directive of use, main indications and perspectives are presented.


CONCLUSIONS
Biomaterials are medical devices planned for tissue reconstruction or substitution. The approval labelling are planned in Europe by the European Community certification (marquage CE) and overseen by a postmarket medical device safety (matériovigilance), that are completely independent from the Food and Drug Administration certification. Indications of biomaterials are likely competitive to those of autografts; their advantage is to limit the morbidity due to autograft harvesting. Benefits are aesthetics, functional or complementary. Main indications are presented in otology, rhinology, face traumatology, laryngology, anti-aging surgery, implants and epithesis. Research fields are scanned (increased therapeutic properties, drug delivery systems, tissue engineering...).


CONCLUSIONS
Biomaterials are increasingly implanted in ENT surgery. The surgical success of their use require a strict legal label and well-defined indications.
Malard
O
O
Service d'ORL et de chirurgie cervicofaciale, CHU Hôtel-Dieu de Nantes, 1, place A.-Ricordeau, BP 1005, 44093 Nantes cedex 01, France. omalard@chu-nantes.fr
Corre
P
P
Bordure
P
P
Weiss
P
P
Grimandi
G
G
Saffarzadeh
A
A
D001672:Biocompatible Materials; D018786:Bone Substitutes; D005147:Facial Bones / Q000601:surgery*; D006257:Head; D006801:Humans; D008437:Maxilla / Q000601:surgery*; D009333:Neck; D013517:Otorhinolaryngologic Surgical Procedures / Q000379:methods*; D019651:Plastic Surgery Procedures / Q000379:methods*
D001672:Biocompatible Materials; D018786:Bone Substitutes